IA
IRWD icon

IndexIQ Advisors’s Ironwood Pharmaceuticals IRWD Stock Holding History

IndexIQ Advisors’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$402K Buy
+31,988
New +$367K 0.01% 647

Other funds holding IRWD

SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

IndexIQ Advisors's IRWD Position: Q1 2022 in Review

IndexIQ Advisors opened a new position in Ironwood Pharmaceuticals (IRWD) in Q1 2022: 31,988 shares worth $402K. The stake represents 0.01% of the portfolio and ranks #647 among its holdings.

221 funds tracked by Wall St. Rank hold IRWD as of Q1 2022.

  • IndexIQ Advisors held 31,988 shares of Ironwood Pharmaceuticals worth $402K as of Q1 2022.
  • Ironwood Pharmaceuticals was a new IndexIQ Advisors position in Q1 2022.
  • Ironwood Pharmaceuticals made up 0.01% of IndexIQ Advisors's portfolio in Q1 2022, its #647 holding.
  • 221 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.